| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 |
| filingDate |
1994-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_958eb4598d8e3872928bc90414dca025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff5dda2b8352f815bdaffc0a0a7f637e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21ae7490f70f9962b649cf6b1d93028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69fd63232989031d3d35c35851b77b00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ddf725ce79027b606c84be772b53717 |
| publicationDate |
1996-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5500434-A |
| titleOfInvention |
Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| abstract |
The invention relates to combinations of angiotensin-converting enzyme inhibitors with calcium antagonists, processes for their preparation and their use as medicaments. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194868-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2543637-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7368469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5721244-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6245787-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005032784-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005101658-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007021491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008287403-A1 |
| priorityDate |
1986-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |